Cardiac Amyloidosis

Amyloidosis refers not to a single disease but to a collection of diseases in which a protein-based infiltrate deposits in tissues as beta-pleated sheets. The subtype of the disease is determined by which protein is depositing; although dozens of subtypes have been described, most are incredibly rare or of trivial importance. This analysis will focus on the main systemic forms of amyloidosis, both of which frequently involve the heart. Cardiac amyloidosis is a devastating and progressive disease. Nurses should be aware of the manifestations of cardiac amyloidosis in order to assist in early diagnosis and treatment. Early diagnosis and treatment provide patients with improved outcomes and better quality of life. Familiarity with the initial signs and symptoms and the progression of cardiac amyloidosis is necessary in order to recognize it.

    Related Conference of Cardiac Amyloidosis

    June 11-12, 2024

    31st Global Nursing and Health Care Conference

    Amsterdam, Netherlands
    June 20-21, 2024

    55th World Nursing and Healthcare Conference

    Dublin, Ireland
    June 27-28, 2024

    61st World Nursing Conference

    London, UK
    July 18-19, 2024

    31st Global Nursing and Healthcare Congress

    Paris, France
    August 08-09, 2024

    43rd World Nursing and Healthcare Conference

    London, UK
    September 04-05, 2024

    World Nursing Congress

    Toronto, Canada
    October 10-11, 2024

    16th International Conference on Gynecology

    Madrid, Spain
    December 04-05, 2024

    4th Global Summit on Nursing Practice

    Orlando, USA

    Cardiac Amyloidosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in